Back to search
Infection Due to ESBL Escherichia Coli
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Infection Due to ESBL Escherichia Coli trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Infection Due to ESBL Escherichia Coli trials you may qualify forThis study evaluates the efficacy in achieving clinical cure in non-bacteremic urinary tract infections (UTI) caused by Escherichia coli or Klebsiella pneumonia…
Enterobacterieaceae (and specially Escherichia coli) showing resistance due to multidrug-resistant Escherichia coli, plasmid mediated AmpC or quinolone resistan…
Escherichia coli is the primary cause of urinary tract infections and Gram-negative bacteremia worldwide. Since the early years of the 21st century, E.coli has…
This study aims to evaluate the impact of contact isolation on the rate of hospital-acquired transmissions of ESBL-producing Escherichia coli (ESBL-EC) and the…
Escherichia coli is the leading cause of community-onset gram-negative bloodstream infections. There has been a dramatic increase in the prevalence of extended-…